Factors Associated With Kidney Disease Progression and Mortality in a Referred CKD Population

被引:54
|
作者
Hoefield, Richard A. [1 ]
Kalra, Philip A. [1 ]
Baker, Patricia [2 ]
Lane, Beverley [1 ]
New, John P. [1 ]
O'Donoghue, Donal J. [1 ]
Foley, Robert N. [3 ,4 ]
Middleton, Rachel J. [1 ]
机构
[1] Univ Manchester, Salford Royal Hosp Fdn Trust, Vasc Res Grp, Manchester Acad Hlth Sci Ctr, Salford, Lancs, England
[2] Univ Manchester, NW Inst Biohlth Informat, Manchester, Lancs, England
[3] Chron Dis Res Grp, Minneapolis, MN USA
[4] Univ Minnesota, Minneapolis, MN USA
关键词
Chronic kidney disease (CKD); estimated glomerular filtration rate (eGFR); epidemiology; progression; mortality; RENAL-INSUFFICIENCY; CARDIOVASCULAR-DISEASE; RISK-FACTORS; DEATH; NEPHROPATHY; REPLACEMENT;
D O I
10.1053/j.ajkd.2010.06.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Knowing how kidney disease progresses is important for decision making in patients with chronic kidney disease (CKD) and for designing clinical services. Study Design: Prospective cohort study. Setting & Participants: We examined renal function trajectories in CRISIS (Chronic Renal Insufficiency Standards Implementation Study), in which 1,325 patients with CKD stages 3-5 and mean age of 65.1 years were followed up prospectively for a median of 26 months after referral to a regional nephrology center in the United Kingdom. By protocol, estimated glomerular filtration rate was determined every 12 months. Predictors: CKD stage defined as estimated glomerular filtration rate > 45 (stage 3a), 30-44 (3b), 15-29 (4), and < 15 (5) mL/min/1.73 m(2). Outcomes: Onset of renal replacement therapy (RRT), death, the composite end point of RRT or death, or decreasing CKD stage. Results: During a median follow-up of 26 months, 13% reached the end point of RRT (5.1 events/100 patient-years), 20% died (9.6 deaths/100 patient-years), and 33% reached the combined end point of RRT or death (14.7 events/100 patient-years). For stage 3a, baseline prevalence and annual probabilities of decreasing CKD stage, RRT, and death were 18.0%, 0.41, 0.01, and 0.02, respectively. Corresponding values for stage 3b were 32.5%, 0.22, < 0.01, and 0.06; for stage 4, 36.5%, 0.17, 0.03, and 0.10; and for stage 5, 13.2%, zero (by definition), 0.31, and 0.08, respectively. Markov model projections suggested a steady decrease for proportions with stages 3a, 3b, and 4; a steady increase for death and RRT; and a biphasic pattern for (non-RRT) stage 5, with a plateau in the first 2 years followed by a steady decrease. Limitations: Single-center observational study. Conclusion: This study suggests that death and RRT are the dominant outcomes in patients referred for management of CKD and that most patients spend comparatively little time in late stages without RRT. Am J Kidney Dis 56: 1072-1081. (C) 2010 by the National Kidney Foundation, Inc.
引用
收藏
页码:1072 / 1081
页数:10
相关论文
共 50 条
  • [2] Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort
    Levin, Adeera
    Djurdjev, Ognjenka
    Beaulieu, Monica
    Er, Lee
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (04) : 661 - 671
  • [3] Clinical characteristics or chronic kidney disease (CKD) and associated disease progression
    Keith, D
    Smith, D
    Nichols, G
    Brown, J
    Ryu, S
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (04) : A20 - A20
  • [4] Mortality of chronic kidney disease (CKD) in a large HMO population.
    Keith, D
    Nichols, G
    Gullion, C
    Brown, J
    Smith, D
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 620A - 620A
  • [5] Factors associated with development or progression of atherosclerotic changes in carotid arteries in patients with chronic kidney disease (CKD)
    Simachowicz, A
    Krupa, D
    Oko, A
    Czekalski, S
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V71 - V71
  • [6] Chronic kidney disease: Aortic stiffening is associated with CKD progression rate
    Lucchese B.
    [J]. Nature Reviews Nephrology, 2010, 6 (7) : 386 - 386
  • [7] RISK FACTORS AND PROGRESSION OF CARDIOVASCULAR (CV) DISEASE IN CHILDREN WITH CHRONIC KIDNEY DISEASE (CKD)
    Doyon, Anke
    Bayazit, Aysun
    Canpolat, Nur
    Duzova, Ali
    Kracht, Daniela
    Litwin, Mieczyslaw
    Ranchin, Bruno
    Shroff, Rukshana
    Soezeri, Betul
    Wuehl, Elke
    Zeller, Rene
    Melk, Anette
    Querfeld, Uwe
    Schaefer, Franz
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 298 - 298
  • [8] Kidney failure, CKD progression and mortality after nephrectomy
    Ellis, Robert J.
    Cameron, Anne
    Gobe, Glenda C.
    Diwan, Vishal
    Healy, Helen G.
    Lee, Jeremy
    Tan, Ken-Soon
    Venuthurupalli, Sree
    Zhang, Jianzhen
    Hoy, Wendy E.
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (09) : 2239 - 2245
  • [9] Kidney failure, CKD progression and mortality after nephrectomy
    Robert J. Ellis
    Anne Cameron
    Glenda C. Gobe
    Vishal Diwan
    Helen G. Healy
    Jeremy Lee
    Ken-Soon Tan
    Sree Venuthurupalli
    Jianzhen Zhang
    Wendy E. Hoy
    [J]. International Urology and Nephrology, 2022, 54 : 2239 - 2245
  • [10] SERUM URIC ACID IS ASSOCIATED WITH CHRONIC KIDNEY DISEASE PROGRESSION AND MORTALITY: INSIGHTS FROM THE CKD-REIN COHORT
    Prezelin-Reydit, Mathilde
    Combe, Christian
    Harambat, Jerome
    Massy, Ziad
    Metzger, Marie
    Lange, Celine
    Lambert, Oriane
    Stengel, Benedicte
    Leffondre, Karen
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1117 - 1117